Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
29 Mar 2016 MYC Overexpressed Triple Negative Breast Cancer Breast cancer - Translational research
25 Mar 2016 Combined Inhibition of DDR1 and Notch Signalling for KRAS-Driven Lung Adenocarcinoma Translational research - Lung and other thoracic tumours
24 Mar 2016 ISO Renews Standards For Safer Medication Bioethics, legal and economic issues
18 Mar 2016 NICE UK: Faster Access to Effective Cancer Treatments Through New Cancer Drugs Fund Bioethics, legal and economic issues
16 Mar 2016 Evaluation of a Single Metastasis in Metastatic Prostate Cancer Genitourinary cancers - Translational research
15 Mar 2016 EMA Reviews PI3K Inhibitor Idelalisib Haematologic malignancies - Anticancer agents & Biologic therapy
14 Mar 2016 FDA Expands Use of Crizotinib in Advanced NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
09 Mar 2016 Atezolizumab in Patients With Locally Advanced and Metastatic Urothelial Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy
08 Mar 2016 Launch of EMA’s Priority Medicines Scheme Bioethics, legal and economic issues
08 Mar 2016 ESMO Open Press Release: High White Blood Cell Ratio Linked to Recurrence Risk in Early Stage Breast Cancer Breast cancer
04 Mar 2016 ESMO is Proud That Charité Connects the Patient Guides to the Clinic’s Website
03 Mar 2016 EMA Recommends Granting a Marketing Authorisation for Generic Palonosetron Palliative and supportive care
02 Mar 2016 EMA Recommends Granting a Marketing Authorisation for Trifluridine/Tipiracil Gastrointestinal cancers - Anticancer agents & Biologic therapy
01 Mar 2016 ESMO mourns the loss of Dr. Holbrook Kohrt
01 Mar 2016 EMA Recommends Extending Indications for Idelalisib Haematologic malignancies - Anticancer agents & Biologic therapy